Home › Compare › VIVXF vs NNN

VIVXF vs NNN: Dividend Comparison 2026

VIVXF yields 2000000.00% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIVXF wins by $4.879226400974806e+39M in total portfolio value
10 years
VIVXF
VIVXF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full VIVXF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — VIVXF vs NNN

📍 VIVXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIVXFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIVXF + NNN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VIVXF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIVXF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, VIVXF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIVXF + NNN for your $10,000?

VIVXF: 50%NNN: 50%
100% NNN50/50100% VIVXF
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

VIVXF
No analyst data
Altman Z
-311.0
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIVXF buys
0
NNN buys
0
No recent congressional trades found for VIVXF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIVXFNNN
Forward yield2000000.00% ✓5.66%
Annual dividend / share$2.00$2.38 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6% ✓
Portfolio after 10y$4.879226400974806e+39M$25.5K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$2,622.67
Total dividends collected$4.879195005460081e+39M$13.7K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VIVXF vs NNN ($10,000, DRIP)

YearVIVXF PortfolioVIVXF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,735$614.96+$200.00M → VIVXF
2$3,738,731,768,458$3,738,517,757,009.35$11,572$708.43+$3738731.76M → VIVXF
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,531$819.53+$65315062866.92M → VIVXF
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,633$952.29+$1066400830062625.00M → VIVXF
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$14,909$1,111.84+$16272182796453826560.00M → VIVXF
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$16,392$1,304.77+$2.3205424011366188e+23M → VIVXF
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$18,129$1,539.52+$3.0927990661046884e+27M → VIVXF
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$20,173$1,827.08+$3.8524105697352695e+31M → VIVXF
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$22,597$2,181.81+$4.484688260147987e+35M → VIVXF
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$25,491$2,622.67+$4.879226400974806e+39M → VIVXF

VIVXF vs NNN: Complete Analysis 2026

VIVXF — Stock

Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Full VIVXF Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this VIVXF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIVXF vs SCHDVIVXF vs JEPIVIVXF vs OVIVXF vs KOVIVXF vs MAINVIVXF vs ADCVIVXF vs EPRTVIVXF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.